Alternagin-C (ALT-C), a disintegrin-like protein, attenuates alpha2beta1 integrin and VEGF receptor 2 signaling resulting in angiogenesis inhibition-Reference-Cited by-同舟云学术

Alternagin-C (ALT-C), a disintegrin-like protein, attenuates alpha2beta1 integrin and VEGF receptor 2 signaling resulting in angiogenesis inhibition

Published:2020-07 Issue: Volume:174 Page:144-158
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

dos Santos Patty K.^ORCID,Altei Wanessa F.^ORCID,Danilucci Taís M.^ORCID,Lino Rafael L.B.^ORCID,Pachane Bianca C.^ORCID,Nunes Ana C.C.^ORCID,Selistre-de-Araujo Heloisa S.^ORCID

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de São Paulo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

General Medicine,Biochemistry

Reference72 articles.

1. Minor snake venom proteins: structure, function and potential applications;Boldrini-França;Biochim. Biophys. Acta Gen. Subj.,2017

2. Snake venom toxins: toxicity and medicinal applications;Chan;Appl. Microbiol. Biotechnol.,2016

3. Snake venomics. Strategy and applications;Calvete;J. Mass Spectrom.,2007

4. Disintegrins from snake venoms and their applications in cancer research and therapy;Macêdo;Curr. Protein Pept. Sci.,2015

5. Aggretin venom polypeptide as a novel anti-angiogenesis agent by targeting integrin alpha2beta1;Chung;Sci. Rep.,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging anticancer potential and mechanisms of snake venom toxins: A review;International Journal of Biological Macromolecules;2024-06

2. The Role of Snake Venom Disintegrins in Angiogenesis;Toxins;2024-03-01

3. Luteolin inhibits angiogenesis and enhances radiotherapy sensitivity of laryngeal cancer via downregulating Integrin β1;Tissue and Cell;2023-12

4. Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease;Biomolecules;2023-10-18

5. Snake venom toxins: Potential anticancer therapeutics;Journal of Applied Toxicology;2023-09-12